Sera Prognostics has secured Illinois Medicaid coverage for its PreTRM test, expanding payer access for tens of thousands of pregnant patients [1].
This legislative win is significant because it validates the economic and clinical value of the company's test-guided care. By removing financial barriers for Medicaid recipients, Sera Prognostics can scale its reach within a major U.S. state and establish a precedent for other payers [2].
The announcement came during the company's second quarter earnings call, which was recorded on Wednesday, Aug. 12 [3]. The move is expected to enable care for up to 50,000 pregnancies each year [1].
"We are thrilled to have secured Illinois Medicaid coverage for the PreTRM test, which will enable care for up to 50,000 pregnancies each year," Jennifer Zibuda, head of investor relations, said [1].
The company's leadership described the coverage as a landmark step toward broader adoption of the PreTRM test. The CEO said the agreement unlocks tens of thousands of births [2].
Looking toward future growth, the company has set specific targets for the coming year. An investor relations officer said the target is 1% to 2% Medicaid penetration in 2027 [4]. This penetration rate is expected to translate into thousands of additional pregnancies [4].
Sera Prognostics, which trades under the ticker SERA, aims to use this coverage to demonstrate the effectiveness of its screening tools in diverse patient populations [2]. The company intends to leverage the Illinois data to argue for broader insurance mandates across the U.S. [2].
“Illinois Medicaid coverage represents a landmark step toward broader adoption of our test.”
Securing government payer coverage is a critical milestone for medical diagnostic companies. By gaining access to the Medicaid population in Illinois, Sera Prognostics not only increases its immediate addressable market but also generates the real-world clinical data necessary to convince private insurers of the test's cost-effectiveness. This move shifts the company from a niche provider to a systemic part of public health infrastructure in the region.
